marijuana stocks news

Will Insys Therapeutics (INSY) Continue to Surge Higher? – Tale of the Tape

As of late, it has definitely been a great time to be an investor in Insys Therapeutics Inc (INSY). The stock has moved higher by 17.3% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.

We certainly think that this might be the case, particularly if you consider INSY’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as INSY has earned itself a Zacks Rank #2 (Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company.

 

 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
1 comment
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

GT Biopharma Inc. (GTBP) Announces GTBP CEO, Dr. Raymond Urbanski, to Make Presentation at the 2018 Wedbush PacGrow Healthcare Conference

GT Biopharma Announces GTBP CEO, Dr. Raymond Urbanski, to Make Presentation at…

$GBLX Appoints Former Nevada State Senator as GM

GrowBLOX Sciences Appoints Former Nevada State Senator Sandra Tiffany as New General…

$CARA Webcast Presentation at 14th Annual Needham Healthcare Conference

Cara Therapeutics to Webcast Presentation at 14th Annual Needham Healthcare Conference SHELTON,…

Village Farms International, Inc. (VFF) Announces Closing of Transaction to Privatize its Fresh Produce Business

Village Farms International Announces Closing of Transaction to Privatize its Fresh Produce…